Phase 1 trial:MVA85A-IMX313 compared with MVA85A

• Research type

  Research Study

• Full title

  A Phase I Randomised Trial to Evaluate the Safety and Immunogenicity of MVA85A-IMX313 compared to MVA85A in BCG vaccinated adults

• IRAS ID

  127997

• Contact name

  Helen McShane

• Contact email

  helen.mcshane@ndm.ox.ac.uk

• Sponsor organisation

  University of Oxford

• Eudract number

  2013-000678-31

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  13/SC/0207

• Date of REC Opinion

  15 May 2013

• REC opinion

  Favourable Opinion